Evidence map›Paper›PMID 30042828›Full record

ArticleOncotarget2018

Combined external beam radiotherapy with carbon ions and tumor targeting endoradiotherapy.

Claudius Melzig, Azadeh Fahim Golestaneh, Walter Mier, Christian Schwager, Samayita Das, Julian Schlegel, Felix Lasitschka, Hans-Ulrich Kauczor, Jürgen Debus, Uwe Haberkorn and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Claudius MelzigGerman Cancer Consortium, Heidelberg, Germany.
Azadeh Fahim GolestanehGerman Cancer Consortium, Heidelberg, Germany.
Walter MierDepartment of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany.
Christian SchwagerGerman Cancer Consortium, Heidelberg, Germany.
Samayita DasGerman Cancer Consortium, Heidelberg, Germany.
Julian SchlegelGerman Cancer Consortium, Heidelberg, Germany.
Felix LasitschkaDepartment of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Hans-Ulrich KauczorDiagnostic and Interventional Radiology, Heidelberg University Hospital, Heidelberg, Germany.
Jürgen DebusGerman Cancer Consortium, Heidelberg, Germany.
Uwe HaberkornDepartment of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany.
Amir AbdollahiGerman Cancer Consortium, Heidelberg, Germany.
University Hospital Heidelberg · DENational Center for Tumor Diseases · DEHeidelberg University · DEGerman Cancer Research Center · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

External beam radiotherapy (EBRT) with carbon ions and endoradiotherapy using radiolabeled tumor targeting agents are emerging concepts in precision cancer therapy. We report on combination effects of these two promising strategies. Tumor targeting

Indexed as

benzamidecarbon ionscetuximabimmune responseradioimmunotherapy (RIT)

Identifiers

PMID30042828
PMCPMC6057461
OpenAlexW2821120435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.